Replimune Group, Inc. Class Action Lawsuit
Company: Replimune Group, Inc.
Ticker: (NASDAQ) REPL
Class Action Period: October 20, 2025 - April 10, 2026
How to Check Whether You May Be Eligible in the Replimune Group, Inc. Class Action
CLASS ACTION PERIOD
October 20, 2025 - April 10, 2026
Allegations
The complaint filed against Replimune Group, Inc. alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (1) in connection with the BLA, the study design concerns previously communicated by the FDA were not addressed; (2) the Company had submitted data from an early unplanned analysis from RP1-104, which included only 40 patients (10% of the planned enrollment of 400 patients); (3) as a result, RPL-001-16 and RP1-104 both had deficiencies which were likely to cause the FDA to reject the BLA; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Eligibility
To be eligible for the lawsuit, you must have experienced a loss on Replimune Group, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Replimune Group, Inc. during the relevant time frame or pursuant to the relevant offering(s), you have until October 5, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How can Replimune Group, Inc. (NASDAQ: REPL) investors check whether their transactions may be relevant?
Investors whose purchases or acquisitions of Replimune Group, Inc. securities fall within the proposed class definition described above may submit their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information for review
The lead plaintiff deadline for this case is October 5, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. No action is required before this date to remain a potential class member.
- Who may be eligible for the Replimune Group, Inc. lawsuit?
Investors whose purchases or acquisitions of Replimune Group, Inc. securities fall within the proposed class definition described above and who suffered financial losses may be eligible.
- Could I still be eligible for the Replimune Group, Inc. lawsuit if I sold my shares?
Yes. Investors whose purchases or acquisitions fall within the proposed class definition may still be eligible even if they later sold their shares.
- How much compensation could I receive from the Replimune Group, Inc. lawsuit?
Any potential compensation would depend on the outcome of the case, the applicable class definition, and any settlement or judgment. If there is a recovery, eligible investors may receive a portion of it.
- What documents may be required for the Replimune Group, Inc. lawsuit?
Investors may be asked to provide transaction records, purchase and sale dates, number of shares, and loss details.
- Will I need to appear in court for the Replimune Group, Inc. lawsuit?
In most cases, investors do not need to appear in court. Whether an investor may need to participate personally depends on their role and developments in the case.
EXPLORE MORE CASES
iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd.
ITOC
Lead Plaintiff Deadline: September 29, 2026
Class Period: September 5, 2024 - July 29, 2025
Bloom Energy Corporation
BE
Bloom Energy Corporation BE Securities Class Action Lawsuit Update
Lead Plaintiff Deadline: September 28, 2026
Class Period: February 27, 2025 - July 8, 2026